Clinical Trial Update: Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial focusing on methods to characterize resistance to antibody-drug conjugates in solid tumors and to identify clinically useful biomarkers a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Non-small Cell Lung Cancer
• Urothelial Cancer

Snippet

Sponsor: UNICANCER | Conditions: Advanced Breast Cancer, Advanced Gastric Cancer | Phase 2 | Status: RECRUITING